Serum interleukin-27 expression in patients with myasthenia gravis

Ha Neul Jeong, Jung Hwan Lee, Bum Chun Suh, Young Chul Choi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Myasthenia gravis (MG)11MG (myasthenia gravis). is an autoimmune disease directed at the neuromuscular junction, and cytokines are thought to contribute to its immunopathogenesis. Interleukin-27 (IL-27)22IL-27 (interleukin-27). plays a complex and pleiotropic role in immune responses associated with T helper cells. To assess the role of IL-27 in MG, we determined serum IL-27 levels in MG patients (n = 32) compared to healthy controls (n = 50). The median serum IL-27 level was significantly higher in MG patients (35.947 pg/mL) than in controls (19.885 pg/mL). Furthermore, serum IL-27 was significantly higher in early onset MG. This study suggests the possibility that IL-27 might contribute to MG pathogenesis or immunoregulation.

Original languageEnglish
Pages (from-to)120-122
Number of pages3
JournalJournal of Neuroimmunology
Volume288
DOIs
Publication statusPublished - 2015 Nov 15

Fingerprint

Interleukin-27
Myasthenia Gravis
Serum
Neuromuscular Junction
Helper-Inducer T-Lymphocytes
Autoimmune Diseases
Cytokines

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Jeong, Ha Neul ; Lee, Jung Hwan ; Suh, Bum Chun ; Choi, Young Chul. / Serum interleukin-27 expression in patients with myasthenia gravis. In: Journal of Neuroimmunology. 2015 ; Vol. 288. pp. 120-122.
@article{da1f1f05ca6f4991a67a72fc5bac3283,
title = "Serum interleukin-27 expression in patients with myasthenia gravis",
abstract = "Myasthenia gravis (MG)11MG (myasthenia gravis). is an autoimmune disease directed at the neuromuscular junction, and cytokines are thought to contribute to its immunopathogenesis. Interleukin-27 (IL-27)22IL-27 (interleukin-27). plays a complex and pleiotropic role in immune responses associated with T helper cells. To assess the role of IL-27 in MG, we determined serum IL-27 levels in MG patients (n = 32) compared to healthy controls (n = 50). The median serum IL-27 level was significantly higher in MG patients (35.947 pg/mL) than in controls (19.885 pg/mL). Furthermore, serum IL-27 was significantly higher in early onset MG. This study suggests the possibility that IL-27 might contribute to MG pathogenesis or immunoregulation.",
author = "Jeong, {Ha Neul} and Lee, {Jung Hwan} and Suh, {Bum Chun} and Choi, {Young Chul}",
year = "2015",
month = "11",
day = "15",
doi = "10.1016/j.jneuroim.2015.09.010",
language = "English",
volume = "288",
pages = "120--122",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",

}

Serum interleukin-27 expression in patients with myasthenia gravis. / Jeong, Ha Neul; Lee, Jung Hwan; Suh, Bum Chun; Choi, Young Chul.

In: Journal of Neuroimmunology, Vol. 288, 15.11.2015, p. 120-122.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum interleukin-27 expression in patients with myasthenia gravis

AU - Jeong, Ha Neul

AU - Lee, Jung Hwan

AU - Suh, Bum Chun

AU - Choi, Young Chul

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Myasthenia gravis (MG)11MG (myasthenia gravis). is an autoimmune disease directed at the neuromuscular junction, and cytokines are thought to contribute to its immunopathogenesis. Interleukin-27 (IL-27)22IL-27 (interleukin-27). plays a complex and pleiotropic role in immune responses associated with T helper cells. To assess the role of IL-27 in MG, we determined serum IL-27 levels in MG patients (n = 32) compared to healthy controls (n = 50). The median serum IL-27 level was significantly higher in MG patients (35.947 pg/mL) than in controls (19.885 pg/mL). Furthermore, serum IL-27 was significantly higher in early onset MG. This study suggests the possibility that IL-27 might contribute to MG pathogenesis or immunoregulation.

AB - Myasthenia gravis (MG)11MG (myasthenia gravis). is an autoimmune disease directed at the neuromuscular junction, and cytokines are thought to contribute to its immunopathogenesis. Interleukin-27 (IL-27)22IL-27 (interleukin-27). plays a complex and pleiotropic role in immune responses associated with T helper cells. To assess the role of IL-27 in MG, we determined serum IL-27 levels in MG patients (n = 32) compared to healthy controls (n = 50). The median serum IL-27 level was significantly higher in MG patients (35.947 pg/mL) than in controls (19.885 pg/mL). Furthermore, serum IL-27 was significantly higher in early onset MG. This study suggests the possibility that IL-27 might contribute to MG pathogenesis or immunoregulation.

UR - http://www.scopus.com/inward/record.url?scp=84945545370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945545370&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2015.09.010

DO - 10.1016/j.jneuroim.2015.09.010

M3 - Article

C2 - 26531704

AN - SCOPUS:84945545370

VL - 288

SP - 120

EP - 122

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -